- Home
- NMTC vs ANTX Comparison
NMTC vs ANTX Comparison
Compare NMTC & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NMTC | ANTX |
|---|---|---|
| Founded | 2009 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.5M | 30.1M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | NMTC | ANTX |
|---|---|---|
| Price | $0.57 | $1.20 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $2.23 | $2.00 |
| AVG Volume (30 Days) | ★ 159.1K | 54.2K |
| Earning Date | 12-15-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $6,629,051.00 | N/A |
| Revenue This Year | $162.84 | N/A |
| Revenue Next Year | $26.51 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 69.00 | N/A |
| 52 Week Low | $0.40 | $1.01 |
| 52 Week High | $1.39 | $1.59 |
Technical Indicators
Market Signals| Indicator | NMTC | ANTX |
|---|---|---|
| Relative Strength Index (RSI) | 32.46 | 58.54 |
| Support Level | $0.66 | $1.03 |
| Resistance Level | $0.75 | $1.21 |
| Average True Range (ATR) | 0.05 | 0.06 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 4.63 | 85.00 |
Price Performance
Historical ComparisonAbout NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.